FILE:CVH/CVH-8K-20110208074850.txt.gz
EVENTS:	Results of Operations and Financial Condition	Financial Statements and Exhibits
TEXT:
ITEM: Results of Operations and Financial Condition
ITEM: Financial Statements and Exhibits
 
 
 
 
SECTION 2  FINANCIAL INFORMATION
ITEM 2.02  Results of Operations and Financial Condition
On February 8, 2011, Coventry Health Care, Inc. (the Company) issued a news release regarding its results of operations for the quarter and twelve months ended December 31, 2010, and its financial condition as of the period then ended. A copy of the news release is furnished herewith as Exhibit 99.1.  The exhibit is not deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act) or incorporated by reference in the Companys filings under the Exchange Act or Securities Exchange Act of 1933, as amended.
SECTION 9  FINANCIAL STATEMENTS AND EXHIBITS
ITEM 9.01  Financial Statements and Exhibits
(d)  Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
 

 
 
Contact:                 John Stelben
Interim Chief Financial Officer
(301) 581-5729
Drew Asher
SVP, Corporate Finance
(301) 581-5717
BETHESDA, Md. (February 8, 2011) - Coventry Health Care, Inc. (NYSE: CVH) today reported consolidated operating results for the quarter and fiscal year ended December 31, 2010.  Operating revenues totaled $3.0 billion for the quarter with net earnings of $150.3 million, or $1.01 earnings per diluted share (EPS).  These results include a favorable impact from the Medicare Advantage Private Fee-for-Service (MA-PFFS) product of $0.05 EPS.  Excluding the impact of MA-PFFS results, core earnings for the quarter were $142.1 million, or $0.96 EPS.
(1)
For the year ended December 31, 2010, total operating revenues were $11.6 billion with net earnings of $438.6 million, or $2.97 EPS.  These results include a favorable impact from the MA-PFFS product of $0.45 EPS and an unfavorable impact from the previously announced Louisiana provider class action litigation of $1.18 EPS.  Excluding the impact of MA-PFFS results and the provider class action charge, core earnings for the year were $546.4 million, or $3.70 EPS.
(1)
(2)
I continue to be pleased with the fundamental performance of our seven core businesses which exceeded our expectations during 2010.  This should position us well as we enter 2011, a year with unique challenges and opportunities as we implement healthcare reform mandates, said Allen F. Wise, chairman and chief executive officer of Coventry.  More importantly, I am pleased with the long-term positioning of our core businesses including our health plans and our ability to seize opportunities and grow in 2012 and beyond.
Fourth Quarter 2010 Consolidated Highlights
 
 
 
 
Selected Fourth Quarter and Full Year 2010 Highlights
Page  2
 
 
 
2011 FULL YEAR GUIDANCE
RECONCILIATION OF 2010 GAAP EPS TO 2010 CORE EPS
                                                  
 
RECONCILIATION OF 2010 CORE EPS TO 2011 EPS GUIDANCE
MIDPOINTS
 
 
ADDITIONAL SELECTED ASSUMPTIONS FOR 2011 GUIDANCE
Page  3
 
 
 
Mr. Allen F. Wise, chairman and chief executive officer of Coventry, will host a conference call at 8:00 a.m. ET on Tuesday, February 8, 2011.  To listen to the call, dial toll-free at (877) 852-6578 or, for international callers, (719) 325-4803. Callers will be asked to identify themselves and their affiliations.  The conference call will also be webcast from Coventrys Investor Relations site at www.coventryhealthcare.com.  Coventry asks participants on both the call and webcast to review and be familiar with its filings with the Securities and Exchange Commission.  A replay of the call will be available for one week at (888) 203-1112 or, for international callers, (719) 457-0820. The access code is 4643959.
 
This press release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are defined as statements that are not historical facts and include those statements relating to future events or future financial performance, including the guidance herein. Actual performance may be significantly impacted by certain risks and uncertainties including those described in Coventrys Annual Report on Form 10-K for the year ended December 31, 2009 and Coventrys subsequent filings with the Securities and Exchange Commission.  Among the factors that may materially affect Coventrys business, operations or financial condition are the ability to accurately estimate and control future health care costs; the a bility to increase premiums to offset increases in the Companys health care costs; general economic conditions and disruptions in the financial markets; changes in laws or regulations or government investigations; changes in government funding for Medicare and Medicaid; a reduction in the number of members in the Companys health plans; the Companys ability to acquire additional managed care businesses and the Companys ability to successfully integrate acquired businesses into its operations; an ability to attract new members or to increase or maintain premium rates; the non-renewal or termination of the Companys government contracts, or unsuccessful bids for business with government agencies; failure of the Companys independent agents and brokers to continue to market its products to employers; a failure to obtain cost-effective agreements with a sufficient number of providers that could result in higher medical costs and a decrease in membership; negative publicity regarding the managed health care industry generally or the Company in particular; a failure to effectively protect, maintain, and develop our information technology systems; periodic reviews, audits and investigations under the Companys contracts with federal and state government agencies; litigation, including litigation based on new or evolving legal theories; volatility in the Companys stock price and trading volume; the Companys indebtedness, which imposes certain restrictions on its business and operations; an inability to generate sufficient cash to service the Companys indebtedness; the Companys certificate of incorporation and bylaws and Delaware law, which could delay, discourage or prevent a change in control of the Company that its stockholders may consider favorable; and an impairment of the Companys intangible assets.  Coventry undertakes no obligation to update or revise any forward-looking statements.
 
Coventry Health Care (www.coventryhealthcare.com) is a diversified national managed healthcare company based in Bethesda, Maryland, operating health plans, insurance companies, network rental and workers compensation services companies.  Coventry provides a full range of risk and fee-based managed care products and services to a broad cross section of individuals, employer and government-funded groups, government agencies, and other insurance carriers and administrators.
Page  4
 
 
 
Page  5
 
 
 
Page  6
 
 
 
Page  7
 
 
 
 
Page  8
 
 
 
Explanatory Notes
Page  9
 


